Lockerman Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,203
Closed -$375K 122
2025
Q1
$375K Sell
1,203
-2
-0.2% -$591 0.57% 58
2024
Q4
$314K Sell
1,205
-56
-4% -$16.6K 0.53% 62
2024
Q3
$406K Buy
1,261
+53
+4% +$17.3K 0.69% 45
2024
Q2
$377K Buy
1,208
+97
+9% +$28.5K 0.68% 44
2024
Q1
$316K Buy
+1,111
New +$325K 0.6% 51
2022
Q4
Sell
-1,014
Closed -$228K 72
2022
Q3
$228K Hold
1,014
0.66% 52
2022
Q2
$247K Hold
1,014
0.79% 46
2022
Q1
$245K Hold
1,014
0.66% 56
2021
Q4
$228K Buy
+1,014
New +$214K 0.6% 57

Other funds holding AMGN

Lockerman Financial Group's AMGN Position: Q2 2025 in Review

Lockerman Financial Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,203 shares — an estimated $375K sold.

Lockerman Financial Group first reported a position in AMGN in Q4 2021 and held it in 9 quarters. The position peaked at $406K in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Lockerman Financial Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Lockerman Financial Group sold 1,203 Amgen shares in Q2 2025, an estimated $375K.
  • Lockerman Financial Group first reported a position in Amgen in Q4 2021 and held it in 9 quarters.
  • Lockerman Financial Group's Amgen position peaked at $406K in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Lockerman Financial Group's 13F filing for Q2 2025, filed 18 Jul 2025.